WaveMan
WaveMan · Company
LEEEF · Leef Brands Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

LEEEF Leef Brands (LEEEF) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Medicinal chemicals & botanical products · CIK 0001711141
Quote by TradingView
Cluster · 3 insidersC-suite buying · 2
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

What the filings say about LEEEF

Insiders, 180 days
+$243.7K net bought
3 buyers

Leef Brands insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Leef Brands Inc. insiders bought a net $243.7K of stock across 4 Form 4 purchases and sales, with 3 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Wilson Kevin John
Chief Financial Officer
BUY
2026-06-16 SECtraded 2026-06-15
464,197
$106.8K
-16.6%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 18, 2026.
  • The trade is 100.0% of the 464,197 shares held after it.
  • 2 other insiders bought within 30 days.
Insider activity: Chief Financial Officer Wilson Kevin John bought about $106.8K of LEEEF on Jun 15, 2026, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
Wilson Kevin John
Chief Financial Officer
BUY
2026-05-21 SECtraded 2026-05-18
54,348
$13.6K
-2.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 6.0% of the 901,581 shares held after it.
  • 2 other insiders bought within 30 days.
Insider activity: Chief Financial Officer Wilson Kevin John bought about $13.6K of LEEEF on May 18, 2026, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
Anderson Micah Payne
Chief Executive Officer
BUY
2026-05-21 SECtraded 2026-05-18
135,870
$34.0K
-2.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 0.9% of the 14,667,726 shares held after it.
  • 2 other insiders bought within 30 days.
Insider activity: Chief Executive Officer Anderson Micah Payne bought about $34.0K of LEEEF on May 18, 2026, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
MENDOLA ROBERT JAMES JR
Director
BUY
2026-10-02 SECtraded 2026-05-18
357,553
$89.4K
-15.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 357,553 shares held after it.
  • 2 other insiders bought within 30 days.
Insider activity: Director MENDOLA ROBERT JAMES JR bought about $89.4K of LEEEF on May 18, 2026, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
4 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$243.7K over 180 days
+$34.0K of it by a 10%+ holder
more than 82% of Pharma & Biotech
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+22.1% year over year
more than 68% of Pharma & Biotech
Margin
-50.7% net margin
more than 50% of Pharma & Biotech
Buybacks
no share repurchases reported
Short interest
0.4% of the float short (float per yahoo 2026-10-26) · 1.1 days to cover · settled 2026-09-30
below 86% of Pharma & Biotech
The situation: each line is one rule over one dataset
3 insiders independently bought a net $243.7K while the stock fell 18% over six months, with no planned sales queued.
What changed in the last 30 days
Oct 28Insider buying stopped: no purchases in 90 days after 4 in the prior 90
Why it matters
The absence is the signal: 4 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.
Oct 2Director MENDOLA ROBERT JAMES JR bought $89.4K (May 18)

Watch LEEEF

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-27.1%12M
-46%-27%-8%+12%2025-102025-122026-022026-042026-062026-082026-10 2026-06-15 · Wilson Kevin John bought $106.8K2026-05-18 · MENDOLA ROBERT JAMES JR bought $89.4K2026-05-18 · Anderson Micah Payne bought $34.0K2026-05-18 · Wilson Kevin John bought $13.6K2026-04-01 · Micah Payne Anderson filed a 5%+ stake (12.2%)
Insider buy13D/G stake
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns LEEEF: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in LEEEF

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

13D: intends to influence · 13G: passive
Micah Payne Anderson
Activist 13D · 2026-04-01
12.2%

LEEEF planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
3 insiders reported buying shares.
The record shows a net $243.7K bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLTWST

LEEEF financials

Revenue growth
+22.1%
XBRL, annual
Net margin
-50.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Cash flow to debt
n/a
needs four quarters of operating cash flow
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
$49.4M
market value at close 2026-10-27 on 2026-08-06 shares, plus long-term debt only, 2024-12-31, minus cash 2026-06-30
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-12
Revenue$34.8M$28.5M
Gross profit$10.5M$7.7M
Operating income-$7.6M-$8.0M
Net income-$17.6M-$24.6M
EPS (diluted)-0.10-0.17
Operating cash flow-$336.9K-$1.0M
Cash$2.2M$2.7M
Long-term debtn/a$10.0M
SEC XBRL, fiscal years, as known on 2026-10-28

LEEEF Stock Sonar score 3/7 axes

Find similar shapesCompare

LEEEF ranks highest on risk and compliance (87th percentile) and insider conviction (85th), and lowest on growth (68th), among Pharma & Biotech peers.

Growth
68
Inputs
  • Revenue growth, YoY+22.1% · 68 pct, sector of 505
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
85
Inputs
  • Net Form 4 buying (codes P and S), 180d$244K · 81 pct, sector of 428
  • Insider buyers, 180d3 · 89 pct, sector of 437
Risk and compliance
87
Inputs
  • Short interest, % of float+0.4% · 87 pct, sector of 813
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Institutional and government, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Financial health needs 1 of 2 inputs, 0 present: equity is zero or negative, the ratio has no meaning; needs four quarters of operating cash flow
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

LEEEF filings, in plain words

Are Leef Brands insiders buying or selling LEEEF?

In the 180 days to 2026-10-28, Leef Brands insiders were net buyers, a net $243.7K across purchases and sales reported on Form 4, by 3 buyers.

Read the full summary

In the 180 days to 2026-10-28, Leef Brands insiders were net buyers of LEEEF, a net $243.7K across purchases and sales reported on Form 4 by 3 buyers. 3 insiders reported purchases in that window. The latest 5% ownership filing is a 13D by Micah Payne Anderson, filed 2026-04-01, for 12.2% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies